CD30+ Peripheral T-cell Lymphoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08870 | Brentuximab vedotin | 1 | Withdrawn | 1 |
| DB11836 | Sapanisertib | 1 | Withdrawn | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08870 | Brentuximab vedotin | 1 | Withdrawn | 1 |
| DB11836 | Sapanisertib | 1 | Withdrawn | 1 |